AJG Short Interest Climbs to Year High While Stock Posts Double-Digit Weekly Gain

Short sellers have rebuilt positions in AJG to their highest level in at least a year, even as the stock has surged 11.3% over the past week to close at $259.26.

Short interest now stands at 3.3% of the free float, representing roughly 8.5 million shares. The climb has been rapid: positions were around 6.1 million shares at the start of October and have risen more than 35% over the past month. The past week alone saw a 4.1% increase in shares short. That puts AJG's short interest at a level not seen in the prior 30 days of data, consistent with the editorial note that this is a year-plus high. The contrast is stark: the stock and its short sellers have moved in opposite directions at speed, with AJG outpacing its closest brokerage peers, BRO gained 10.7% on the week and AON 8.0%, while RYAN led the group at 13.3%.

The borrow market tells a low-conviction story on the short side. Cost to borrow is 0.52%, barely moved from where it was a month ago at 0.48%, and availability is exceptionally loose at 778%, meaning there are roughly eight shares available to lend for every one already borrowed. That is well within the normal range and close to the 52-week trough of tight conditions rather than the peak: the tightest availability got over the past year was 675%, still a generous lending market by any standard. With borrow this cheap and shares this easy to source, the short build looks opportunistic rather than a conviction trade where lenders are being squeezed. Options positioning adds a wrinkle: the put/call ratio has risen to 0.52, more than two standard deviations above its 20-day average of 0.41. That is the most defensive options posture AJG has seen in recent months, though it remains well below the 52-week high of 0.91, leaving room for further hedging demand.

The Street has spent much of the past six weeks trimming price targets without abandoning positive ratings. Morgan Stanley cut its target twice in the period, most recently to $260 on October 6, while maintaining Overweight. Wells Fargo lowered to $284 on October 12, also keeping Overweight. Mizuho and RBC similarly shaved targets while holding Outperform ratings. The mean consensus target is $283, implying roughly 9% upside from the current price. The forward earnings picture is the standout factor: AJG ranks in the 97th percentile on 12-month forward EPS growth year-on-year, a reading that has drawn bulls to the acquisition-driven growth model the company has pursued. Against that, EPS surprise ranks only in the 12th percentile, and the EV/EBITDA multiple has drifted higher to 13.3x over the past 30 days as the stock has re-rated. Bears point to P&C market headwinds and integration risk from ongoing M&A as the most credible threats to the margin expansion thesis.

On the institutional side, FMR added 3.8 million shares in the quarter to September 30, the largest single reported change among the top holders, lifting its stake to 6.5% of shares outstanding. BlackRock and State Street both added modestly. JPMorgan Chase, by contrast, disclosed in a July 13G/A that its stake had fallen from 7.8% to 5.5%, though as with all 13D/G disclosures, that position reflects where it stood at the time of filing and may have moved further since.

Earnings are due October 29. The most recent prior print, in July, produced a one-day decline of 7.2% and a five-day decline of 6.4%, a reminder that the reaction function on results has been negative even when the broader trend is constructive. The next release will test whether the current short rebuild reflects positioning ahead of that risk or a more durable bearish thesis on the insurance cycle.